Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zenithhealthcare.com | |
Market Cap | 23.75 Cr. | |
Enterprise Value(EV) | 22.05 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.02 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 194.69 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 31.87 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 1.39 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 3.19 | Calculated using Price: 4.42 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 5.37 Cr. | 53,739,000 Shares |
FaceValue | 1 | |
Company Profile | ||
Zenith Healthcare is engaged in the manufacturing of tablets, capsules, ointments, and liquid injectable among others. |
1 Day |
|
+4.74% |
1 Week |
|
+15.10% |
1 Month |
|
+9.14% |
3 Month |
|
-21.21% |
6 Month |
|
-22.73% |
1 Year |
|
-40.27% |
2 Year |
|
-27.90% |
5 Year |
|
+505.48% |
10 Year |
|
+820.83% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -4.37 | -4.06 | -5.45 | -2.78 | 4.95 | 2.38 | 9.27 | 6.64 | 4.44 | |
Return on Capital Employed (%) | -6.48 | -5.82 | -8.24 | -3.04 | 7.38 | 2.95 | 9.68 | 8.56 | 8.85 | |
Return on Assets (%) | -3.90 | -3.73 | -5.00 | -2.55 | 4.37 | 2.03 | 7.60 | 5.28 | 3.11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 6 | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 3 | |
Minority Int. | |||||||||||
Equity & Liab. | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 12 | 11 | |
Non Curr. Assets | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |
Curr. Assets | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 10 | 9 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | 12 | 11 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 3 | 4 | 3 | 5 | 10 | 10 | 12 | 14 | 22 | 19 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |
Total Income | 3 | 4 | 4 | 5 | 10 | 10 | 12 | 14 | 23 | 20 | |
Total Expenditure | -4 | -4 | -4 | -5 | -9 | -10 | -11 | -13 | -22 | -19 | |
PBIDT | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | -1 | 1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | |||||||
Net Change | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 1 | -2 | 1 | |
Cash & Cash Eqvt | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 2 |
Fri, 17 Mar 2023
Board Meeting Intimation for NOTICE OF INDEPENDENT DIRECTORS MEETING ZENITH HEALTH CARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/03/2023 inter alia to consider and approve The meeting of the Independent Directors of the Company will be held on Tuesday 28th March 2023 at 5.00. P.M. at the Registered Office of the Company to transact the following businesses: 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To review the performance of Chairman (elected) of the Company taking into account the views of executive directors and non-executive directors.3. To access the Quality Quantity and timeliness of flow of Information between the management of the company and the board of directors that is necessary for the board of directors to effectively and reasonably perform their duties.4. Any other Business with the permission of the Chair. |
Mon, 13 Feb 2023
Board Meeting Outcome for Unaudited Standalone Financial Results For The Quarter And Nine-Months Ended December 31 2022. Unaudited Standalone Financial Results for the Quarter and Nine-Months ended December 31 2022. |
Mon, 13 Feb 2023
Unaudited Standalone Financial Results For The Quarter And Nine-Months Ended December 31 2022. Unaudited Standalone Financial Results for the Quarter and Nine-Months ended December 31 2022. |
Fri, 24 Mar 2023 |
|
|
|
|
|